Clal Biotechnology reported ILS-1.74M in Operating Profit for its fiscal quarter ending in December of 2022.





Operating Profit Change Date
aTyr Pharma USD -26.74M 6.43M Sep/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
RedHill Biopharma USD -4.22M 1.8M Jun/2024